To test this hypothesis we used a double transgenic mouse model (referred to as APP/tau mice) that we previously generated by replacing the mutant PS1 allele with its wild type counterpart in the 3×Tg-AD mice, thereby obtaining double transgenic mice expressing APP and tau [47]. The gene discussed is MAPT; the disease is Alzheimer disease.